Rectal cancer lateral lymph nodes: multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes.


Journal

The British journal of surgery
ISSN: 1365-2168
Titre abrégé: Br J Surg
Pays: England
ID NLM: 0372553

Informations de publication

Date de publication:
12 03 2021
Historique:
received: 18 05 2020
revised: 06 07 2020
accepted: 29 08 2020
entrez: 12 3 2021
pubmed: 13 3 2021
medline: 29 4 2021
Statut: ppublish

Résumé

In patients with rectal cancer, enlarged lateral lymph nodes (LLNs) result in increased lateral local recurrence (LLR) and lower cancer-specific survival (CSS) rates, which can be improved with (chemo)radiotherapy ((C)RT) and LLN dissection (LLND). This study investigated whether different LLN locations affect oncological outcomes. Patients with low cT3-4 rectal cancer without synchronous distant metastases were included in this multicentre retrospective cohort study. All MRI was re-evaluated, with special attention to LLN involvement and response. More advanced cT and cN category were associated with the occurrence of enlarged obturator nodes. Multivariable analyses showed that a node in the internal iliac compartment with a short-axis (SA) size of at least 7 mm on baseline MRI and over 4 mm after (C)RT was predictive of LLR, compared with a post-(C)RT SA of 4 mm or less (hazard ratio (HR) 5.74, 95 per cent c.i. 2.98 to 11.05 vs HR 1.40, 0.19 to 10.20; P < 0.001). Obturator LLNs with a SA larger than 6 mm after (C)RT were associated with a higher 5-year distant metastasis rate and lowered CSS in patients who did not undergo LLND. The survival difference was not present after LLND. Multivariable analyses found that only cT category (HR 2.22, 1.07 to 4.64; P = 0.033) and margin involvement (HR 2.95, 1.18 to 7.37; P = 0.021) independently predicted the development of metastatic disease. Internal iliac LLN enlargement is associated with an increased LLR rate, whereas obturator nodes are associated with more advanced disease with increased distant metastasis and reduced CSS rates. LLND improves local control in persistent internal iliac nodes, and might have a role in controlling systemic spread in persistent obturator nodes.Members of the Lateral Node Study Consortium are co-authors of this study and are listed under the heading Collaborators.

Sections du résumé

BACKGROUND
In patients with rectal cancer, enlarged lateral lymph nodes (LLNs) result in increased lateral local recurrence (LLR) and lower cancer-specific survival (CSS) rates, which can be improved with (chemo)radiotherapy ((C)RT) and LLN dissection (LLND). This study investigated whether different LLN locations affect oncological outcomes.
METHODS
Patients with low cT3-4 rectal cancer without synchronous distant metastases were included in this multicentre retrospective cohort study. All MRI was re-evaluated, with special attention to LLN involvement and response.
RESULTS
More advanced cT and cN category were associated with the occurrence of enlarged obturator nodes. Multivariable analyses showed that a node in the internal iliac compartment with a short-axis (SA) size of at least 7 mm on baseline MRI and over 4 mm after (C)RT was predictive of LLR, compared with a post-(C)RT SA of 4 mm or less (hazard ratio (HR) 5.74, 95 per cent c.i. 2.98 to 11.05 vs HR 1.40, 0.19 to 10.20; P < 0.001). Obturator LLNs with a SA larger than 6 mm after (C)RT were associated with a higher 5-year distant metastasis rate and lowered CSS in patients who did not undergo LLND. The survival difference was not present after LLND. Multivariable analyses found that only cT category (HR 2.22, 1.07 to 4.64; P = 0.033) and margin involvement (HR 2.95, 1.18 to 7.37; P = 0.021) independently predicted the development of metastatic disease.
CONCLUSION
Internal iliac LLN enlargement is associated with an increased LLR rate, whereas obturator nodes are associated with more advanced disease with increased distant metastasis and reduced CSS rates. LLND improves local control in persistent internal iliac nodes, and might have a role in controlling systemic spread in persistent obturator nodes.Members of the Lateral Node Study Consortium are co-authors of this study and are listed under the heading Collaborators.

Identifiants

pubmed: 33711144
pii: 6114692
doi: 10.1093/bjs/znaa009
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

205-213

Investigateurs

M Kusters (M)
J Tuynman (J)
R Hompes (R)
T Akiyoshi (T)
T Konishi (T)
G A P Nieuwenhuijzen (GAP)
H J T Rutten (HJT)
D P Schaap (DP)
H Iversen (H)
A Martling (A)
C Suzuki (C)
E Meershoek-Klein-Kranenbarg (E)
A Ogura (A)
H Putter (H)
C J H van de Velde (CJH)
J Garcia-Aguilar (J)
M J Gollub (MJ)
T Aiba (T)
A Ogura (A)
K Uehara (K)
A G J Aalbers (AGJ)
G L Beets (GL)
R G H Beets-Tan (RGH)
M Maas (M)
M Betts (M)
C Cunningham (C)
H X Lee (HX)
J Moore (J)
T Sammour (T)
M Thomas (M)
T Wells (T)
P Lee (P)
M J Solomon (MJ)
M H Choi (MH)
M K Kim (MK)
I K Lee (IK)
S N Oh (SN)
D D Won (DD)
Y Hanaoka (Y)
H Kuroyanagi (H)
S Toda (S)
K Tomizawa (K)
H Rutten (H)
K G Brown (KG)
P Lee (P)
M J Solomon (MJ)

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of BJS Society Ltd. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

D P Schaap (DP)

Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.

L S F Boogerd (LSF)

Department of Surgery, Amsterdam University Medical Centres, Location VUmc, Amsterdam, the Netherlands.

T Konishi (T)

Department of Gastroenterological Surgery, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.

C Cunningham (C)

Department of Colorectal Surgery, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

A Ogura (A)

Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Department of Surgery, Leiden University Medical Centre, Leiden, the Netherlands.

J Garcia-Aguilar (J)

Department of Surgery, Memorial Sloan Kettering Cancer Centre, New York, USA.

G L Beets (GL)

Department of Surgery, Netherlands Cancer Institute, Amsterdam, the Netherlands.

C Suzuki (C)

Department of Radiology, Karolinska Institutet, Stockholm, Sweden.

S Toda (S)

Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan.

I K Lee (IK)

Department of Surgery, Seoul St Mary's Hospital, Catholic University of Korea, Seoul, Korea.

T Sammour (T)

Department of Surgery, Royal Adelaide Hospital and University of Adelaide, Adelaide, South Australia, Australia.

K Uehara (K)

Department of Gastroenterological Surgery, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.

P Lee (P)

Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Surgical Outcomes Research Centre (SOuRCe), Sydney Local Health District and Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia.

J B Tuynman (JB)

Department of Surgery, Amsterdam University Medical Centres, Location VUmc, Amsterdam, the Netherlands.

C J H van de Velde (CJH)

Department of Surgery, Leiden University Medical Centre, Leiden, the Netherlands.

H J T Rutten (HJT)

Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.
Maastricht University, GROW, School of Oncology and Developmental Biology, Maastricht, the Netherlands.

M Kusters (M)

Department of Surgery, Amsterdam University Medical Centres, Location VUmc, Amsterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH